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Abstract: This study examined the relationship between the frequency of coffee consumption and 
blood pressure over a two year follow up of a cohort of elderly people. Healthy, older people (N = 
205) were examined at baseline and at two years. Participants completed physical and behavioural 
assessments, which included body composition, current pharmacological treatment, and frequency 
of coffee consumption grouped into three categories: “never to a few times per month”, “once a 
week to a few times per week”, and “every day”. Blood pressure (systolic (sBP), diastolic (dBP), 
mean (mBP), and pulse pressure (PP)) was measured at baseline and after two years. After adjusting 
for body composition, smoking status, age, sex, heart rate, and number of antihypertensive agents 
taken, participants who drank coffee everyday had a significant increase in sBP, with a mean of 8.63 
(1.27; 15.77) and an mBP, with a mean of 5.55 mmHg (0.52; 10.37) after two years (t = 2.37, p = 0.02 
and t = 2.17, p = 0.03, respectively) compared to participants who never or very rarely (up to a few 
times per month) drank coffee. DBP and PP were not affected by coffee consumption frequency in 
a statistically significant manner. 




The aetiology of hypertension is unclear in most cases, but is associated with multiple 
risk factors [1]. Prevalence of hypertension is higher (two times more) in older compared 
to younger populations [2]. Aging, which is a time-associated decline in tissue 
functionality, increases the risk of developing metabolic syndromes. Aged-related 
changes, such as chronic inflammation, endothelial dysfunction, a decrease in elastin, an 
increase in collagen and calcification of arteries, an increase in sympathetic nervous 
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system activity, and an increase in aldosterone production and salt sensitivity, are 
potential factors that could increase the occurrence of hypertension [3]. Several studies 
showed that aging thickens the walls of large conduit arteries, thereby decreasing their 
elasticity. Higher arterial stiffness reduces the compliance of arteries in close proximity to 
the heart, leading to higher systolic and pulse pressure. Therefore, isolated systolic 
hypertension might be a result of age-related cardiovascular alterations [2]. 
1.2. Coffee 
Coffee is a widely consumed pharmacologically active beverage. Coffee 
consumption in the European community is similar to that in the United States, which is 
estimated to be 5.1 kg/year per person [4]. Coffee contains caffeine and thousands of other 
chemical compounds, including lipids, carbohydrates, nitrogenous, minerals, vitamins, 
alkaloids, and phenolic compounds [5]. 
1.3. Acute Effects of Coffee Consumption on BP 
Coffee ingestion has an acute effect by increasing blood pressure. Ingestion of two to 
three cups of coffee increases systolic blood pressure (sBP) by 3–14 mmHg and diastolic 
blood pressure (dBP) by 4–13 mmHg [6]. The acute pressor effect of coffee might be more 
pronounced in those who are not habitual coffee drinkers [6]. The blood pressure 
dysregulations, which were observed after acute coffee intake, were attributed to caffeine. 
Studies have demonstrated that caffeine promotes sympathetic antagonism of adenosine 
receptor, norepinephrine release via direct effects on the adrenal medulla, activation of 
the renin angiotensin renal system, and might be the mechanism of coffee-related acute 
hypertension [7]. In contrast, the benefits of caffeine ingestion in young healthy men were 
also reported. Acute administration of caffeine led to improvement in endothelial 
vasodilatory function. [8]. Nevertheless, animal model studies showed reduced 
catecholamines circulating levels with chronic caffeine consumption [9]. Importantly, 
there is a remarkable and fast blood pressure adaptation to coffee consumption, which 
appears just a few days after the first intake and attenuates the coffee-related acute 
increase in blood pressure [10,11]. 
1.4. Chronic Effects of Coffee Consumption on BP 
Currently, coffee consumption is not considered a risk factor for hypertension 
development. However, results derived from studies of chronic coffee consumption and 
its effect on blood pressure are ambiguous. Higher coffee intake was associated with a 
lower risk of developing hypertension [12]. However, high coffee consumption was also 
related to high blood pressure, but this effect could be smoking-dependent [12,13]. A 
systematic meta-analysis concluded that routine coffee consumption of more than three 
cups per day was not related to a higher risk of hypertension when compared to low 
consumption (less than one cup per day) [14]. 
The aim of our study was to examine the relationship between the frequency of coffee 
consumption and changes in blood pressure over a two year follow up period in an elderly 
cohort. 
2. Materials and Methods 
2.1. Study Group 
2.1.1. Sample Size Calculation 
The sample size calculation was conducted using the general linear mixed model 
power and sample size 3.0 calculator (GLIMMPSE 3.0) [15]. The study presented here was 
part of a larger study, for which the primary outcome was the score change in cognitive 
function. The sample size was, therefore, calculated as described previously [16]. 
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2.1.2. Study Recruitment 
The study recruitment is summarised in Figure 1. In total, 407 participants (95 males) 
took part in the baseline series of assessments, with 205 returning two years later for a 
second assessment (40 males). The comparison between patients re-examined compared 
to those who were dropouts was described in our previous paper [16]. 
 
Figure 1. Flow chart of the study. 
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Recruitment of subjects was done via advertisements on regional television and 
radio, during the delivery of health-promoting public lectures at Collegium Medicum 
University, and in meetings of organizations associated with older people in Bydgoszcz, 
day care centres for the elderly. These advertisements contained information about the 
opportunity to take part in a free-of-charge examination, including behaviour, body 
composition, and health state, for people 60 years and over in age. Study volunteers were 
excluded from participation if they were under 60 years of age. The study was approved 
by the ethics committee, Ludwik Rydygier Memorial Collegium Medicum in Bydgoszcz, 
Nicolaus Copernicus University, Torun (KB 340/2015). Written informed consent was 
obtained from all participants. 
2.2. Assessment Methods 
2.2.1. Blood Pressure Measurement and Hypertension History Treatment and 
Assessment 
All examinations were completed in a doctor’s office. Heart rate (HR) was assessed 
by grasping the wrist and measuring via the palpation method, with the variable 
expressed as beats per minute. Blood pressure was measured on both of the upper limbs 
in a consecutive manner after at least 5 min of rest. The mean value for each systolic blood 
pressure (sBP) and diastolic blood pressure (dBP) reading from these two measurements 
were analysed. The pulse pressure (PP) was calculated using the formula: PP = sBP − dBP. 
During bassline, as well as the follow up after two years, the patients were asked about 
drugs taken, including type and dosage. The answers were encoded from market names 
to names of active compounds. Then, four categories were established: subjects who were 
not taking antihypertensives drugs in either time points (no to no), which was established 
as a referring group, and participants who were taking antihypertensive drugs at both 
time-points (yes to yes). Subjects who were not taking antihypertensive drugs during 
baseline, but started to take them after two years, were classified as “no to yes”. 
Participants who were taking antihypertensive drugs during baseline, but ceased taking 
them after two years, were classified as “yes to no”. 
2.2.2. Frequency of Coffee Consumption 
Coffee consumption frequency at the follow up time point was examined. 
Participants were asked to recall the frequency of coffee consumption over the last two 
years. Answers on questions about frequency of coffee consumption were coded in the 
following way: “never” was coded as 0, “once a year” as 1, “several times a year” as 2, “1–
2 times a month” as 3, “once a week” as 4, “a few times a week” as 5, and “daily” as 6. 
Then, three categories were distinguished: “never to a few times per month”, “once a 
week to a few times per week”, and “every day”. 
2.2.3. Body Composition Analysis 
A Tanita BC-545 body-fat analyser was used to measure weight and body fat both 
before and after two years. Bioelectric impedance analysis (BIA) was used to measure 
body composition. Muscle mass was predicted in kilograms and included into the analysis 
as an alternative to body mass index, which is not an effective body composition predictor 
[17]. 
2.3. Statistical Analysis 
The R package was used to perform statistical analysis [18]. To compare results of 
tests before vs. after two years, a dependent t-test was used for analysis if the assumption 
was met, otherwise the Wilcoxon test was used. Ggstatsplot package [19] was used to 
calculate effect sizes and their confidence intervals [−95%; 95%] for dependent 
comparisons. 
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Linear mixed models, with restricted maximum likelihood, and the Satterthwaite 
method, to perform t-tests, were carried out using the Lme4 and LmerTest packages [20] 
to assess the influence of analysed factors on the change of blood pressure (before vs. after 
two years). Random effects included the subject and time factors, while the rest of the 
factors included were set as fixed. Both intercepts and slopes were considered as random. 
The confidence interval (95%) for the coefficient parameters was calculated using the 
“confint” command to calculate 5000 simulations using the bootstrap method. The 
“R2beta” command was used to calculate the R2 value and its confidence interval (−95%; 
95%). A graph illustrating the linear mixed models results was created using the “Dwplot” 
command. 
3. Results 
The mean age of the participants after the two years follow up assessment was 69.67 
(−95% CI = 68.85; 95% CI = 70.5, range 60–88). Table A1 presents the distribution of 
education level of the re-examined group. Most of participants (84.39%) obtained full 
secondary education or higher. Eighty-six percent of participants were characterized by a 
high occupational status (with the highest obtained occupational statuses during lifetime 
including: a white collar worker, a white collar worker in a managerial position, an owner 
of craft/entrepreneur, military/policeman/other uniformed services, or seller/employee of 
trade). Table 1 presents the descriptive statistics of the qualitive predictors included in the 
model that was used to explain the variance of changes in blood pressure scores after two 
years. 
Table 1. Quantitative variables included in linear mixed model. 
Variables Mean ± SD 
Age before (years) 69.67 ± 6 
Muscle mass before (kg) 45.54 ± 8.2 
Muscle mass after two years (kg) 44.87 ± 6.7 
HR before (bpm) 67.57 ± 8 
HR after (bpm) 69.6 ± 9.8 
HR – heart rate. 
The fixed predictors included in our model were age at the initial time point (before 
two years), muscle mass measured after two years, difference in heart rate (HR) in supine 
position after two years, and the number of hypertensive agents taken between the two 
time points. 
Table 2 show the prevalence of active tobacco smokers between the two time points. 
Data on the frequency of coffee consumption, sex, and smoking status was included in the 
linear mixed models. Table A2 presents the time points when the analysed variables were 
measured. 
Table 2. Qualitative variables included in linear mixed model. 
Parameter Level of Estimate Number % 
Sex 
Male 40 19.5 
Female 165 80.5 
Current smoker 
No 165 80.5 
Yes 38 18.5 
Missing data 2 1 
Anti-HT drugs 
yes to no 10 4.9 
yes to yes 62 30.2 
no to yes 49 23.9 
no to no 84 41 
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Coffee consumption frequency 
never to a few times per month 19 9.3 
once a week to a few times per week 26 12.7 
every day 160 78 
In the first time point, 101 (49.27%) participants were diagnosed with hypertension 
during their lifetime. After the two years follow up, this number increased to 107 
participants (52.2%), with an average diagnostic age of 59.6 years old (−95% CI = 57.45; 
95% CI = 61.75). 
No statistically significant changes in blood pressure were observed after the two 
year follow up. The sBP decreased without statistical significance (140.26 ± 19 vs. 137.73 ± 
18 mmHg, loge(VWilcoxon) = 9.29, p = 0.13, r = 0.11 [−0.02; 0.25]) (Figure 2a). No significant 
changes in dBP were noted (85.06 ± 10.7 vs. 84.49 ± 12.1 mmHg, loge(VWilcoxon) = 9.16, p = 
0.42, r = 0.06 [−0.07; 0.2]) (Figure 2b). No significant changes mBP were noted (103.28 ± 12.5 
vs. 102.06 ± 12.7 mmHg, loge(VWilcoxon) = 9.33, p = 0.25, r = 0.08 [−0.04; 0.22]) (Figure 2c). No 
significant changes in PP were noted (55.20 ± 13.3 vs. 53.25 ± 14 mmHg, loge(VWilcoxon) = 
9.36, p = 0.06, r = 0.13 [−0.01; 0.25]) (Figure 2d). 
 
Figure 2. Changes of blood pressure within two years. (a) change in systolic blood pressure (sBP) before vs. after 2 years, 
(b) change in diastolic blood pressure (dBP) before vs after 2 years, (c) change in mean blood pressure (mBP) before vs 
after 2 years, (d) change in pulse pressure (PP) before vs after 2 years. The shape of the violin graph denotes the distribution 
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of values. A horizontal black line inside the box denotes the median value, while the turquoise dots connected by dashed 
grey lines indicate the results of individual participants. Dark red dots connected by a light red line indicate the arithmetic 
mean value. 
Table 3 summarizes the comparison of blood pressure before vs. after two years. 
Table 3. Comparison blood pressure before vs. after two years. 
Variable Mean ± SD before Mean ± SD after 2 Years  loge(VWilcoxon) p-Value 
sBP 140.26 ± 19 137.73 ± 18 9.29 0.13 
dBP 85.06 ± 10.7 84.49 ± 12.1 9.16 0.42 
mBP 103.28 ± 12.5 102.06 ± 12.7 9.33 0.25 
PP 55.20 ± 13.3 53.25 ± 14 9.36 0.06 
sBP – systolic blood pressure, dBP – diastolic blood pressure, mBP – mean blood pressure, PP – 
pulse pressure. 
Figure 3a and Table S1 present the results of a mixed linear model with sBP as the 
predicted variable. The model explained 7% (5%; 15%) of the variance in the change of 
sBP score before vs. after two years. For every additional year of age, there was a decrease 
after two years in the sBP of −0.42 mmHg ((−0.78; −0.093), t = −2.27, p = 0.02). Participants 
who drank coffee everyday had a significant increase in sBP compared to participants 
who drank coffee never or very rarely (never to a few times per month), with a mean of 
8.32 mmHg (1.18; 15.91) after two years (t = 2.27, p = 0.02). A decrease of HR of 1 bpm after 
two years was related to a decrease in sBP by −0.28 mmHg (−0.53; −0.02) after 2 years (t = 
−2.13, p = 0.03). Subjects who were taking antihypertensive drugs before and after two 
years had a decrease in sBP by −6.22 mmHg ((−11.4; −1.11), t = −2.34, p = 0.02). The model 
that predicted changes in mBP explained 6% (5%; 15%) of the variance (Figure 3c and 
Table S3). Participants who drank coffee everyday had a significant increase in mBP 
compared to participants who drank coffee never or very rarely (never to a few times per 
month), with a mean of 5.55 mmHg (0.52; 10.37) after two years (t = 2.17, p = 0.03). A 
decrease of HR by 1 bpm after two years was related to a decrease in mBP by −0.23 mmHg 
(−0.4; −0.04) after 2 years (t = −2.43, p = 0.02). Figure 3d and Table S4 presents the results of 
the mixed linear model with PP as the predicted variable. The model explained 7% (5%; 
16%) of the variance in the change of the PP score before vs. after two years. For every 
additional year of age, there was a decrease after two years in PP of −0.5 mmHg ((−0.78; 
−0.22), t = −3.76, p = 0.0002). Patients who were taking antihypertensive drugs before and 
after two years noted a decrease in PP by −4.79 mmHg ((−8.63; −0.93), t = −2.49, p = 0.001) 
in comparison to patients who did take antihypertensive drugs at either time point. The 
model predicting changes in dBP explained 5% (4%; 13%) of the variance. A decrease of 
HR by 1 bpm after two years was related to a decrease in mBP by −0.2 mmHg (−0.36; −0.02) 
after 2 years (t = −2.25, p = 0.03) (Figure 3b, Table S2). 




Figure 3. Mixed linear model predicting blood pressure changes. (a) change in systolic blood pressure (sBP) before vs after 
2 years, (b) change in diastolic blood pressure (dBP) before vs after 2 years, (c) change in mean blood pressure (mBP) 
before vs after 2 years, (d) change in pulse pressure (PP) before vs after 2 years. The vertical axis denotes predictors of 
change in blood pressure, while the horizontal axis illustrates dynamics of blood pressure before vs. after two years. The 
“0” on the horizontal axis denotes no changes in blood pressure within two years (denoted by a vertical dashed line). 
Predictors with negative estimates are placed on the left side of the dashed line (factors associated with a decrease in blood 
pressure after two years). Predictors with positive estimates are placed on the right side of the dashed line. Red horizontal 
lines illustrate predictors in which both confidence interval values are lower than 0, while blue illustrates predictors in 
which confidence interval values of estimates cross zero. Green indicate predictors in which both confidence interval 
values of estimates are greater than 0. “*” mean predictors that are statistically significant (p < 0.05). “Δ HR in supine 
[bpm]” denotes heart rate (HR) in supine position both after two years and before. “Anti-HT drugs no to yes vs. no to no” 
denotes patients who were not taking antihypertensive drugs during baseline, but started to take after two years in 
comparison to patients who did not take antihypertensive drugs at either time point. “Anti-HT drugs yes to no vs. no to 
no” denotes patients who were taking antihypertensive drugs during baseline, but ceased to take them after two years in 
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comparison to patients who did not take antihypertensive drugs at either time point. “Anti-HT drugs yes to yes vs. no to 
no” denotes patients who were taking antihypertensive drugs during baseline and after two years in comparison to 
patients who did not take antihypertensive drugs at either time point. 
4. Discussion 
4.1. Realtionship between Coffee Consumption and Blood Pressure 
Our study examined a cohort of older people in Poland, and found that drinking 
coffee every day was associated with an increase in sBP, with of mean 8.63 mmHg, and  
mBP, with a mean of 5.85 mmHg, over two years as compared to the subgroup who never 
or very rarely drank coffee. Moreover, a moderate increase in blood pressure was noted 
in everyday coffee drinkers in comparison to a subgroup who drank once to a few times 
per week. The results showed that dBP and PP were not statistically significantly affected 
by coffee consumption frequency. 
An association between a higher intake of coffee consumption and a lower risk of 
hypertension was noted [12]. In contrast, high coffee consumption was related to high 
blood pressure [13]. Navarro et al., in longitudinal study on 13.374 participants with a 
mean age of 35.7 (SD = 10.4), noted that the higher the habitual coffee consumption, the 
lower the risk of hypertension [21]. According to findings of Navarro et al., authors of a 
meta-analysis of cohort studies noted a dose-dependent relationship between habitual 
coffee consumption and the risk of hypertension [22]. Subjects with no coffee intake were 
compared to those who drank two, four, six, and eight cups of coffee/day, wherein the 
higher the amount of cups/day of coffee, the lower the risk of hypertension [22]. In a study 
on 8780 participants (aged 49 (43–55)), it was noted that the relationship between coffee 
consumption and hypertension occurrence was related to smoking status [23]. Moderate 
coffee intake (1–3 cups/day) decreased the risk of hypertension in those who had never 
smoked [23]. De Giuseppe noted that, due to methodological inaccuracies, it is impossible 
to get a consensus on the relationship between habitual coffee consumption and blood 
pressure changes [24]. 
4.2. Possible Confounding Factors in Relationship between Coffee Consumption and Blood 
Pressure 
Chlorogenic acid seemed to be a physiologically significant polyphenol with 
antioxidant properties present in coffee [25]. The total antioxidant activity of coffee 
depends upon the chemical composition and the degree to which the beans are roasted, 
with medium-roasted characterised by the highest antioxidant activity [26]. The 
antioxidant activity of coffee might be different due to method by which the coffee 
prepared, with espresso characterised as having the highest and decaffeinated coffee as 
having lower antioxidant activity, respectively. In the current study, no distinction 
between caffeinated vs. decaffeinated was made, but we assumed that the majority of 
coffee ingested was of the caffeinated form [27]. Moreover, unfiltered coffee might contain 
higher amounts of diterpenes, which were related to increasing circulating levels of total 
cholesterol and in low density lipoprotein form [5]. In addition, the results of recent 
studies suggested that coffee consumption might alter the gut microbiome [28], and this 
alternation might be clinically relevant [29]. The authors propose that non-digestible 
prebiotic included in coffee might mediate this effect, however, there is a requirement for 
further studies to explore this in more detail [30]. Furthermore, some health benefits from 
caffeine intake might be mediated via activation of the nuclear factor erythroid 2-related 
factor-2 system [30]. In addition, the effects of coffee consumption might be modified by 
genetic factors. Participants with higher genetic risk were characterised by high BP in 
relation to higher coffee consumption [13]. In contrast to that observation, a recent study 
was unable to confirm that genetic variance related to caffeine metabolism affect in the 
relationship between coffee consumption and cardiovascular disorder risk [31]. Therefore, 
further studies on coffee consumption should utilise a longitudinal approach with deep 
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phenotyping methods to assess different pharmacologically active ingredients of coffee 
on human physiology on multi-level dimensions. 
4.3. Physiological Differences between Systolic and Diastolic Blood Pressure 
In our current study, the frequency of coffee consumption was related to sBP, but not 
dBP. As discussed above, isolated systolic hypertension might be a result of age-
associated changes in the cardiovascular system [2]. Pulse pressure is one of the indicators 
of aortic stiffness [32]. 
4.4. Study Limitations 
In the current study, only self-reported recall of the frequency of coffee consumption 
was measured, without an indication of the quantity nor quality. Such methods should be 
incorporated in future longitudinal studies conducted in Poland. As mentioned, the 
method of coffee preparation has an influence on the quality and quantity of substances 
introduced upon consumption [5,33,34]. It was not possible to analyse the method of 
coffee preparation in the currently analysed sample. It was reported that 45% consumed 
coffee made with powder, while 40% consumed instant coffee as the most common form 
in Poland [35]. Based on the questionnaire results from 398 responders in Poland, 48% 
drink espresso prepared under pressure in a machine. In total, 42% preferred pouring hot 
water over coffee (coffee in a glass or cup, without filtering, with coffee grounds) [36]. 
Therefore, arguably it might be predicted that the vast majority of coffee prepared by the 
participants in the current sample was prepared using those two methods. In our previous 
study, we highlighted a need for further longitudinal studies and the incorporation of a 
more representative sample with a higher proportion of males [16]. The results of previous 
studies indicated between-sex differences in the health effects of phenolic compounds 
[37]. Older females were characterised by better tolerability of frailty related to aging [38]. 
In addition, many between-sex differences in the trajectory of inflammation, metabolism, 
and allostatic load were noted [39]. Between-sex differences in the health effects of 
habitual coffee drinking were noted in a meta-analysis of prospective trials, where lower 
risk of coronary heart disease was noted in a group of female habitual coffee drinkers [40]. 
In addition, participants who regularly drink coffee might also be characterised by 
different patterns of behaviour. Mattioli et al. noted a good adherence to the 
Mediterranean diet and high levels of physical activity in a group of women with high 
coffee consumption [34]. In the current study, the pattern of diet and physical activity was 
not evaluated in an objective manner, therefore the current results could not be adjusted 
by those factors. Results of the current study should be adjusted not only by the presence, 
or absence, of antihypertension drug treatment, but also by the precise hypertension 
duration, specific antihypertensive drug type, its quantity, and dosage. In addition, the 
method of recruitment into study via mass media could have led to bias, as well as high 
dropout rate, and should also be considered a limitation [16]. 
5. Conclusions 
In this study we found, in a cohort of older people in Poland, that the daily 
consumption of coffee was related to an increase in sBP and in mBP over two years when 
compared to a subgroup who never or very rarely drank coffee. Moreover, the increase in 
blood pressure in daily coffee drinkers, compared to a subgroup who drink once to a few 
times per week, was noted, however, it was not statistically significant. DBP and PP were 
not affected by coffee consumption frequency in a statistically significant manner. 
Supplementary Materials: The following are available online at 
www.mdpi.com/article/10.3390/nu13103372/s1, Table S1: Mixed linear model predicting systolic 
blood pressure changes, Table S2: Mixed linear model predicting diastolic blood pressure changes., Table 
S3: Mixed linear model predicting mean blood pressure changes., Table S4: Mixed linear model predicting 
pulse pressure changes. 
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Appendix A 
Table A1. Distribution of education categories in the re-examined group. 




Primary education 3 1.46 









Master’s degree 52 25.37 
PhD degree and higher 3 1.46 
Table A2. Time points at which the variables included in linear mixed model were measured. 
Variables 
Time Points at which the Variables were 
Measured 
Coffee consumption after 
Age (years) before 
Sex before 
Current smoker after 
Muscle mass before (kg) before and after two years 
Anti-HT drugs (quantity) before and after two years 
Δ in HR (bpm) before and after two years 
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